Literature DB >> 8917129

The biological basis of panic disorder.

J H Krystal1, D N Deutsch, D S Charney.   

Abstract

Research over the past decade has advanced our understanding of the neuroanatomical and neurochemical substrates of anxiety disorders, including panic disorder. For example, the results of challenge studies with a variety of panicogenic agents that operate by diverse pharmacologic mechanisms have suggested a network model of panic involving dysregulation of multiple neuronal systems. Genetic analyses are consistent with a heritable predisposition, or "panic diathesis," that confers an increased susceptibility to pharmacologic challenge, even in subjects with no overt history of panic disorder. Functional imaging studies confirm preclinical investigations of the anatomical basis of anxiety and provide further evidence for a network of related brain regions mediating the genesis of anxious and fearful behaviors, including panic attacks. Taken together, this research offers a theoretical framework for the ongoing development of improved diagnostic and treatment options.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917129

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex.

Authors:  Brian P Ramos; Amy F T Arnsten
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

2.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

3.  Fear as the main feature of epileptic seizures.

Authors:  A Biraben; D Taussig; P Thomas; C Even; J P Vignal; J M Scarabin; P Chauvel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

Review 4.  Panic disorders: The role of genetics and epigenetics.

Authors:  Eun Jeong Kim; Yong-Ku Kim
Journal:  AIMS Genet       Date:  2018-07-27

Review 5.  Putting the "mental" back in "mental disorders": a perspective from research on fear and anxiety.

Authors:  Vincent Taschereau-Dumouchel; Matthias Michel; Hakwan Lau; Stefan G Hofmann; Joseph E LeDoux
Journal:  Mol Psychiatry       Date:  2022-01-26       Impact factor: 13.437

6.  Pharmacoeconomic evaluation of venlafaxine compared with citalopram in generalized anxiety disorder.

Authors:  Jingjing Zhang; Hongbing Xu; Zhiqing Chen
Journal:  Exp Ther Med       Date:  2012-12-20       Impact factor: 2.447

7.  Norepinephrine drives persistent activity in prefrontal cortex via synergistic α1 and α2 adrenoceptors.

Authors:  Zizhen Zhang; Steven Cordeiro Matos; Sonia Jego; Antoine Adamantidis; Philippe Séguéla
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.